News
April 4, 2014

Controlling Compliance Risk in Global Clinical Research Activities

Pharmaceutical Compliance Monitor

By Daniel A. Kracov Mahnu V. Davar
Find more content tagged:

People

Daniel A. Kracov
Daniel A. Kracov
Partner
Washington, DC
+1 202.942.5120
Email
VCard
Mahnu V. Davar
Mahnu V. Davar
Partner
Washington, DC
+1 202.942.6172
Email
VCard

Related Content

July 31, 2020
Update: Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs has now been adopted
BioSlice Blog
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept